Your World, Fully Explored.
Published loading...Updated

Anne Wojcicki’s Nonprofit Gets Court Approval to Buy 23andMe for $305 Million

  • On June 30, 2025, the U.S. Bankruptcy Court approved the sale of San Francisco-based 23andMe's assets to TTAM Research Institute for $305 million.
  • The sale followed 23andMe's March bankruptcy filing amid financial struggles and months of bidding between TTAM, led by co-founder Anne Wojcicki, and Regeneron Pharmaceuticals.
  • TTAM, a California nonprofit, will acquire 23andMe's Personal Genome Service and Lemonaid Health subsidiary while pledging to maintain privacy policies and allow customers to delete data or opt out of research.
  • Mark Jensen, 23andMe's board chair, called the approval a milestone ensuring the company’s mission to help people understand the human genome persists globally, while Wojcicki said TTAM will build on 23andMe's mission and empower individuals' control over their genetic data.
  • Despite court approval, several states including California actively oppose the sale citing genetic privacy law violations, and customers will receive at least two business days’ notice with privacy details before the transaction closes.
Insights by Ground AI
Does this summary seem wrong?

122 Articles

All
Left
24
Center
63
Right
10
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 65% of the sources are Center
65% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

npr broke the news in Washington, United States on Monday, June 30, 2025.
Sources are mostly out of (0)